-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
China has achieved full coverage of clinical trials on 5 technical routes for new crown vaccine research and development |
China News Service, September 7th.
On the 7th, Zheng Zhongwei, the leader of the vaccine research and development team of the scientific research team and director of the Science and Technology Development Center of the National Health Commission, said on the 7th that China’s deployment of new coronavirus vaccines develops all vaccines for 5 technical routes.
Achieved full coverage of clinical trials
.
On the 7th, the State Council's Joint Prevention and Control Mechanism held a press conference on furthering the situation regarding epidemic prevention and control and vaccination
.
A reporter asked at the meeting: As early as the beginning of last year, my country has deployed five technical routes for the development of new coronavirus vaccines.
State Council
In this regard, Zheng Zhongwei pointed out that China has laid out 5 technical routes from the beginning of the outbreak to promote the research and development of new coronavirus vaccines, including inactivated vaccines, adenovirus vector vaccines, recombinant protein vaccines, attenuated influenza virus vector vaccines and nucleic acid vaccines.
, The main purpose is to ensure the success rate
.
"Here I can give you a clear message.
So far, all vaccines of our 5 technical routes have achieved full coverage of clinical trials
.
" Zheng Zhongwei said, of which 3 inactivated vaccines have been attached by the State Food and Drug Administration.
Focus on the new crown pneumonia epidemic